Flerie Invest

Flerie Invest is a venture capital firm specializing in early-stage life science, biotechnology, and pharmaceutical investments, based in Stockholm, Sweden, with an additional office in London. Operating as a publicly listed investment company on the Nasdaq Stockholm exchange under the ticker FLERIE, the firm utilizes an evergreen structure to provide long-term capital support from pre-clinical phases through commercial growth. The organization primarily targets drug development companies focused on cell and gene therapies, vaccines, biologics, and small molecules across Europe, the United States, and Israel. Managed by a core team of five employees, the firm operates without the fixed terms of traditional venture funds to enable sustained backing for complex medical challenges. Its active investment portfolio includes life science enterprises such as Empros Pharma, Prokarium, NorthX Biologics, and Xspray Pharma. Flerie Invest was founded in 2011 by Thomas Eldered.